Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1,25%
1 110,47
+13,75
+1,25%
1 096,721 098,741 113,821 098,74
SIXC
Communications
SIXC
Communications
SIXC
-1,19%
604,07
-7,25
-1,19%
611,32611,32611,32603,33
SIXE
Energy
SIXE
Energy
SIXE
+2,56%
1 201,49
+29,95
+2,56%
1 171,541 176,151 202,381 176,15
SIXI
Industrials
SIXI
Industrials
SIXI
+1,01%
1 765,30
+17,67
+1,01%
1 747,631 747,671 770,511 744,43
SIXM
Financials
SIXM
Financials
SIXM
-0,17%
630,42
-1,07
-0,17%
631,49631,23633,90627,95
SIXR
Staples
SIXR
Staples
SIXR
-1,00%
841,45
-8,49
-1,00%
849,94850,23850,23836,20
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,35%
218,83
+0,77
+0,35%
218,06218,06219,96218,02
SIXT
Technology
SIXT
Technology
SIXT
+1,31%
3 582,23
+46,20
+1,31%
3 536,033 549,423 590,523 543,38
SIXU
Utilities
SIXU
Utilities
SIXU
+0,97%
913,89
+8,82
+0,97%
905,07908,07916,83907,68
SIXV
Health care
SIXV
Health care
SIXV
-0,38%
1 444,33
-5,53
-0,38%
1 449,861 451,341 464,451 440,75
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,72%
2 412,96
-17,51
-0,72%
2 430,472 415,842 422,952 396,14
RPGLIFE:NSE
RPG Life Sciences Ltd
₹2 409,60
-2,17%
(-53,50) 1D
11 Mei, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RPGLIFE...
Open
₹2 480,00
High
₹2 480,00
Low
₹2 409,00
Mkt. cap
39,85 mjd
Avg. vol.
77,89 k
Volume
11,68 k
P/E ratio
34,60
52-wk high
₹2 725,00
52-wk low
₹1 733,00
EPS
₹69,64
Shares outstanding
16,54 m
No. of employees
1 k
News stories
From sources across the web
Profile
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
About RPG Life Sciences Ltd
CEO-
Employees1,33 k
Founded1993
Headquarters-
SectorPharmaceutical industry
Last report
30 Apr. 2026
Fiscal Period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
1,77 mjd / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
1,69 mjd
1,82 mjd
1,80 mjd
1,77 mjd
Cost of goods sold
600,20 m
665,80 m
649,00 m
605,90 m
Cost of revenue
600,20 m
665,80 m
649,00 m
605,90 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
337,00 m
361,60 m
353,20 m
363,00 m
Operating expense
785,70 m
812,90 m
807,50 m
892,10 m
Total operating expenses
1,39 mjd
1,48 mjd
1,46 mjd
1,50 mjd
Operating income
303,30 m
338,10 m
343,80 m
270,90 m
Other non operating income
52,30 m
45,40 m
34,10 m
44,90 m
EBT including unusual items
354,30 m
494,50 m
291,20 m
402,00 m
EBT excluding unusual items
354,30 m
382,30 m
375,40 m
311,90 m
Income tax expense
91,40 m
126,00 m
69,90 m
103,00 m
Effective tax rate
25,80%
25,48%
24,00%
25,62%
Other operating expenses
397,30 m
399,10 m
400,50 m
471,70 m
Net income
262,90 m
368,50 m
221,30 m
299,00 m
Net profit margin
15,56%
20,28%
12,29%
16,90%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1,30 m
-1,20 m
-2,50 m
-3,90 m
Net interest expenses
-1,30 m
-1,20 m
-2,50 m
-3,90 m
Depreciation and amortization charges
51,40 m
52,20 m
53,80 m
57,40 m
EBITDA
355,25 m
389,90 m
395,75 m
324,60 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more